Drugs / Red blood cell transfusion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial · 1 met primary | ||||||
| Phase 1 | NCT02086773 | Apr 2014 → Sep 2015 | acute lymphoblastic leukemia, acute promyelocytic leukemia | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Completed | Met primary |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02465125 Comparator | Jul 2015 → Dec 2016 | abdominal aortic aneurysm, anemia, arterial occlusion, atherosclerosis | Naestved Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Red blood cell transfusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02086773 ↗ |
| Modality | Other / unclassified | “Biological: Red blood cell transfusion” NCT02086773 ↗ |